跳至主要内容
临床试验/NCT00982514
NCT00982514Unknown不适用

Thromboembolic Complications Related to Asparaginase in Children With ALL Treated According to NOPHO ALL 2008

Oslo University Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2009年9月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
1
主要终点
Clinical evident thrombosis

研究概览

简要总结

The study will examine the prevalence of venous thromboembolism in children with acute lymphoblastic leukaemia treated in accordance with NOPHO ALL-2008. The investigators will prospectively study clinical symptomatic thromboses, asymptomatic central line-associated thromboses, and infections.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
1 Year 至 16 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Acute lymphoblastic leukaemia,
  • Age 1 year to 16 years old,
  • Central line,
  • Protocol NOPHO ALL 2008.

排除标准

  • Refusal of participation,
  • Treated according to protocol other than NOPHO ALL 2008.

结局指标

主要结局

Clinical evident thrombosis

时间窗: 33 weeks

Asymptomatic central line-associated thrombosis

时间窗: 33 weeks

次要结局

  • Positive blood culture(33 weeks)

研究者

发起方
Oslo University Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验